STERIS (STE) stock price, revenue, and financials

STERIS market cap is $20.8 b, and annual revenue was $3.11 b in FY 2021

$20.8 B

STE Mkt cap, 24-Jun-2022

$1.2 B

STERIS Revenue Q2, 2022
STERIS Gross profit (Q2, 2022)480.3 M
STERIS Gross profit margin (Q2, 2022), %40.1%
STERIS Net income (Q2, 2022)69.6 M
STERIS EBIT (Q2, 2022)116.5 M
STERIS Cash, 30-Sept-2021383.5 M
STERIS EV24.1 B
Get notified regarding key financial metrics and revenue changes at STERISLearn more
Banner background

STERIS Revenue

STERIS revenue was $3.11 b in FY, 2021 which is a 2.5% year over year increase from the previous period.

Embed Graph

STERIS Revenue Breakdown

Embed Graph

STERIS revenue breakdown by business segment: 23.1% from Capital equipment, 23.4% from Consumable and 53.5% from Service

STERIS revenue breakdown by geographic segment: 71.7% from United States, 26.0% from Other Foreign Countries and 2.3% from Other

STERIS Income Statement

STERIS Balance Sheet

Annual

USDFY, 2019FY, 2020FY, 2021

Cash

220.6m319.6m220.5m

Accounts Receivable

564.8m586.5m609.4m

Prepaid Expenses

60.0m54.4m66.8m

Inventories

208.2m248.3m315.1m

Current Assets

1.1b1.2b1.2b

PP&E

1.0b1.1b1.2b

Goodwill

2.3b2.4b3.0b

Total Assets

5.1b5.4b6.6b

Accounts Payable

152.9m149.3m157.0m

Short-term debt

19.8m22.8m

Current Liabilities

465.2m503.6m577.9m

Long-term debt

1.2b1.3b1.8b

Total Debt

1.2b1.3b1.8b

Total Liabilities

1.9b2.0b2.7b

Common Stock

2.0b2.0b2.0b

Retained Earnings

1.3b1.6b1.9b

Total Equity

3.2b3.4b3.9b

Debt to Equity Ratio

0.4 x0.4 x0.5 x

Debt to Assets Ratio

0.2 x0.2 x0.3 x

Financial Leverage

1.6 x1.6 x1.7 x

STERIS Cash Flow

Annual

USDFY, 2019FY, 2020FY, 2021

Net Income

305.1m407.8m396.9m

Depreciation and Amortization

225.9m197.2m219.2m

Accounts Receivable

(48.5m)(17.9m)12.1m

Inventories

(14.6m)(39.1m)3.8m

Accounts Payable

21.2m(2.8m)(7.2m)

Cash From Operating Activities

539.5m590.6m689.6m

Purchases of PP&E

(189.7m)(214.5m)(239.3m)

Cash From Investing Activities

(213.2m)(319.7m)(1.2b)

Long-term Borrowings

(112.1m)(26.5m)(65.5m)

Dividends Paid

(112.5m)(123.0m)(133.8m)

Cash From Financing Activities

(294.8m)(163.1m)345.6m

Net Change in Cash

19.1m98.9m(99.0m)

STERIS Ratios

USDQ3, 2019

Revenue/Employee

58.0k

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

1.6 x

STERIS Operating Metrics

STERIS's Backlog was reported to be $409.5m in Q2, 2022.
FY, 2016Q3, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020FY, 2020Q1, 2021Q2, 2021Q3, 2021FY, 2021Q1, 2022Q2, 2022

Backlog

$278.1 m$215.2 m$246.1 m$269 m$281.5 m$242.5 m$231.9 m$252.8 m$297.5 m$286.2 m$346.4 m$409.5 m

Countries

100100100

Patent Applications (Foreign)

375360335

Patent Applications (US)

135145140

Patents (Foreign)

1.1 k1.5 k1.64 k1.78 k

Patents (US)

390400410450

Patents Pending

470

Remaining Performance Obligations

$780 k$900 k$921 k$922 k$960 k$940 k$930 k$971 k$1.01 m$1.06 m$1.37 m$1.37 m

Trademarks

1.55 k1.43 k1.67 k

STERIS Employee Rating

3.8127354 votes
Culture & Values
3.8
Work/Life Balance
3.4
Senior Management
3.5
Salary & Benefits
3.9
Career Opportunities
3.9
Source